Division of Molecular Medicine and Gene Therapy
41 – 60 of 569
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
-
Mark
Direct Reprogramming of Mouse and Human Fibroblasts into Conventional Dendritic Cells Type 1
(
- Contribution to journal › Published meeting abstract
-
Mark
Pyruvate metabolism guides definitive lineage specification during hematopoietic emergence
(
- Contribution to journal › Article
-
Mark
Targeting elevated heme levels to treat a mouse model for Diamond-Blackfan Anemia
(
- Contribution to journal › Article
-
Mark
Inflammatory Alveolar Type 2 Cells in Chronic Obstructive Pulmonary Disease : Impairing or Improving Disease Outcome?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Small Molecule Screening of Primary Human Acute Myeloid Leukemia Using Co-culture and Multiplexed FACS Analysis
(
- Contribution to journal › Article
-
Mark
A somatic mutation in moesin drives progression into acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #6 : A Venture Based in Cellular Reprogramming-An Interview with Dr. Cristiana Pires
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #5 : Regeneration, a Natural Reprogramming Process-An Interview with Dr. Nicholas Leigh
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Compositions, constructs and vectors for cell reprogramming (NK cell reprogramming).
2022) WO2022129542(
- Patent › Patent
-
Mark
Ciliated (FOXJ1+) Cells Display Reduced Ferritin Light Chain in the Airways of Idiopathic Pulmonary Fibrosis Patients
(
- Contribution to journal › Article
-
Mark
The 2022 International Society for Stem Cell Research (ISSCR) Annual Meeting : Celebrating 20 Years of Achievements
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway
(
- Contribution to journal › Article
-
Mark
Modeling normal and malignant hematopoiesis in vitro. To screen for extrinsic regulators and differentiation therapy.
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
BMPR1a Is Required for the Optimal TGFβ1-Dependent CD207+ Langerhans Cell Differentiation and Limits Skin Inflammation through CD11c+ Cells
(
- Contribution to journal › Article
-
Mark
Human CIDEC transgene improves lipid metabolism and protects against high-fat diet–induced glucose intolerance in mice
(
- Contribution to journal › Article
-
Mark
New hallmarks of ageing : a 2022 Copenhagen ageing meeting summary
(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #9 : Spacing Out Cellular Reprogramming-An Interview with Dr. Valentina Fossati
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector
(
- Contribution to journal › Article
-
Mark
Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells
(
- Contribution to journal › Article